ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 46 filers reported holding ARATANA THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $11,345,000 | -12.8% | 1,580,116 | +13.7% | 0.00% | -33.3% |
| Q3 2016 | $13,005,000 | +57.2% | 1,389,403 | +6.2% | 0.00% | +50.0% |
| Q2 2016 | $8,271,000 | +23.8% | 1,308,679 | +8.1% | 0.00% | 0.0% |
| Q1 2016 | $6,683,000 | +0.0% | 1,210,672 | +1.1% | 0.00% | 0.0% |
| Q4 2015 | $6,681,000 | -38.3% | 1,197,270 | -6.5% | 0.00% | -33.3% |
| Q3 2015 | $10,834,000 | -42.1% | 1,280,624 | +3.5% | 0.00% | -25.0% |
| Q2 2015 | $18,710,000 | -6.1% | 1,237,439 | -0.6% | 0.00% | -20.0% |
| Q1 2015 | $19,927,000 | -7.2% | 1,244,678 | +3.2% | 0.01% | 0.0% |
| Q4 2014 | $21,484,000 | +216.7% | 1,205,622 | +78.4% | 0.01% | +150.0% |
| Q3 2014 | $6,784,000 | -27.9% | 675,662 | +12.1% | 0.00% | -33.3% |
| Q2 2014 | $9,406,000 | +124.4% | 602,554 | +166.8% | 0.00% | +200.0% |
| Q1 2014 | $4,191,000 | +21.3% | 225,815 | +24.8% | 0.00% | 0.0% |
| Q4 2013 | $3,455,000 | +14.5% | 180,916 | -2.0% | 0.00% | 0.0% |
| Q3 2013 | $3,017,000 | – | 184,622 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 5,184,942 | $31,784,000 | 4.70% |
| AWM Investment Company, Inc. | 1,562,517 | $9,578,000 | 1.67% |
| Opaleye Management Inc. | 420,000 | $2,574,000 | 0.91% |
| MPM ASSET MANAGEMENT LLC | 250,000 | $1,533,000 | 0.75% |
| GENERAL AMERICAN INVESTORS CO INC | 867,600 | $5,318,000 | 0.50% |
| Grandeur Peak Global Advisors, LLC | 538,363 | $3,300,000 | 0.50% |
| Redmond Asset Management, LLC | 55,941 | $343,000 | 0.16% |
| WOODSTOCK CORP | 88,303 | $541,000 | 0.10% |
| CADENCE CAPITAL MANAGEMENT LLC | 173,808 | $1,065,000 | 0.07% |
| Sheaff Brock Investment Advisors, LLC | 71,000 | $435,000 | 0.06% |